Reply
Karim J. Halazun, Abbas A. Rana, Rachel E. Patzer, Benjamin Samstein, Robert S. Brown, Jean C. Emond – 11 September 2014
Reply
Cynthia Guy, Ayako Suzuki, Manal Abdelmalek, James Burchette, Anna Mae Diehl – 11 September 2014
Waiting time and transplantation for hepatocellular cancer: A balance between tempus fugit and carpe diem
Quirino Lai, Jan Lerut, For the European Hepatocellular Cancer Liver Transplant (EurHeCaLT) Study Group – 11 September 2014
What is the future of pediatric liver transplantation? Optimal management of long‐term recipients
Robert S. Venick – 11 September 2014
Adverse cardiac events after orthotopic liver transplantation: A cross‐sectional study in 389 consecutive patients
Ramona Nicolau‐Raducu, Marina Gitman, Donald Ganier, George E. Loss, Ari J. Cohen, Hamang Patel, Nigel Girgrah, Krish Sekar, Bobby Nossaman – 11 September 2014 – Current American College of Cardiology/American Heart Association guidelines caution that preoperative noninvasive cardiac tests may have poor predictive value for detecting coronary artery disease in liver transplant candidates.
Skeletal muscle abnormalities and outcomes after liver transplantation
Aldo J. Montano‐Loza – 11 September 2014
Potential catalysts in postoperative management/critical care
Geraldine Diaz – 11 September 2014
Different histological sequelae of immune‐mediated graft dysfunction after interferon treatment in transplanted dual grafts from living donors
Mizuki Ninomiya, Shinichi Aishima, Tomoharu Yoshizumi, Toru Ikegami, Huanlin Wang, Norifumi Harimoto, Shinji Ito, Hideaki Uchiyama, Yuji Soejima, Hirofumi Kawanaka, Ken Shirabe, Yoshihiko Maehara – 11 September 2014
GLI2 as a marker of hedgehog‐responsive cells
Candice Alexandra Grzelak, Nicholas David Sigglekow, Geoffrey William McCaughan – 11 September 2014
A score model for the continuous grading of early allograft dysfunction severity
Eugenia Pareja, Miriam Cortes, David Hervás, José Mir, Andrés Valdivieso, José V. Castell, Agustín Lahoz – 10 September 2014 – Early allograft dysfunction (EAD) dramatically influences graft and patient outcomes. A lack of consensus on an EAD definition hinders comparisons of liver transplant outcomes and management of recipients among and within centers. We sought to develop a model for the quantitative assessment of early allograft function [Model for Early Allograft Function Scoring (MEAF)] after transplantation.